TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biolin Scientific AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
142,469
|
111,700
|
104,285 |
Financial expenses |
479
|
438
|
238 |
Earnings before taxes |
24,156
|
19,651
|
14,698 |
EBITDA |
27,352
|
24,612
|
20,414 |
Total assets |
144,387
|
115,321
|
102,221 |
Current assets |
51,048
|
34,409
|
25,023 |
Current liabilities |
29,852
|
26,443
|
26,581 |
Equity capital |
113,492
|
88,099
|
74,893 |
- share capital |
26,927
|
25,143
|
25,922 |
Employees (average) |
24
|
21
|
23 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
78.6%
|
76.4%
|
73.3% |
Turnover per employee |
5,936
|
5,319
|
4,534 |
Profit as a percentage of turnover |
17.0%
|
17.6%
|
14.1% |
Return on assets (ROA) |
17.1%
|
17.4%
|
14.6% |
Current ratio |
171.0%
|
130.1%
|
94.1% |
Return on equity (ROE) |
21.3%
|
22.3%
|
19.6% |
Change turnover |
22,843
|
10,549
|
15,951 |
Change turnover % |
19%
|
10%
|
18% |
Chg. No. of employees |
3
|
-2
|
4 |
Chg. No. of employees % |
14%
|
-9%
|
21% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.